Opportunity Information: Apply for CDC RFA GH12 1232
Apply for CDC RFA GH12 1232
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Partnering with Hanoi Medical University to Build Capacity and Implement Program Evaluation, Research, and Health System Strengthening in the Socialist Republic of Vietnam under the Presidents Plan for Emergency Plan for AIDS Relief (PEPFAR)." and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Apr 7, 2012 and posted on Feb 14, 2012.
- Applicants must submit their applications by Apr 16, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,230,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $230,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The purpose of this funding opportunity announcement is to build capacity within the health system of the Government of Vietnam (GVN). The overarching goal is to build and expand institutional capacity within the GVN to coordinate and implement evaluations, research, operations and management of HIV/AIDS and other public health programs and to effectively respond to health system strengthening needs, as identified by GVN and other stakeholders.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Partnering with Hanoi Medical University to Build Capacity and Implement Program Evaluation, Research, and Health System Strengthening in the Socialist Republic of Vietnam under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a CDC-funded cooperative agreement focused on strengthening Vietnam's public health and HIV response systems through institutional capacity building. Its central purpose is to help the Government of Vietnam (GVN) improve how it plans, coordinates, and manages evaluation and research activities tied to HIV/AIDS and other public health programs, while also improving broader health system functions that support effective service delivery. The opportunity is framed around the idea that long-term progress depends not only on program funding, but on building durable national capability to design studies, evaluate performance, use evidence in decision-making, and respond to emerging health system needs identified by the GVN and other stakeholders.
The overarching goal is to expand the institutional capacity within the Vietnamese health system to carry out program evaluation, research, and operations and management functions for HIV/AIDS and related public health priorities. In practice, this typically implies developing stronger national and institutional mechanisms for monitoring and evaluation, operational research, and the translation of findings into policy and program adjustments. The partnership emphasis, explicitly referencing Hanoi Medical University, signals a capacity-building approach that leverages academic and technical institutions as long-term anchors for training, mentorship, analytical support, and implementation science. The health system strengthening element indicates that the work is not limited to narrow HIV program activities; it is intended to address system-level gaps that affect performance, such as workforce capability, data quality and use, coordination structures, and management processes.
This funding is offered as a discretionary cooperative agreement, meaning CDC would likely maintain substantial involvement in the project compared with a typical grant, collaborating on technical direction, work planning, and performance monitoring. The activity category is health, and the award is linked to CFDA 93.067 (Global AIDS), aligning the work with PEPFAR objectives and the broader global HIV/AIDS response framework. The announcement anticipates a single award, suggesting the program was designed for one primary implementing partner to lead coordination and execution, rather than distributing funds across multiple independent recipients.
In terms of funding scale and timing, the estimated total funding listed is $3,230,000, with an award ceiling of $230,000 (as presented in the source data). The opportunity was posted on February 14, 2012, created on April 7, 2012, and had an application closing date of April 16, 2012, with an archive date of May 16, 2012. No cost sharing or matching was required, which lowers barriers for eligible applicants and keeps the focus on technical merit and implementation capacity rather than the applicant's ability to contribute additional funds.
Eligibility is described broadly as "Others" with further clarification referenced in an additional eligibility section of the full announcement. While the excerpt does not list specific eligible entity types, the title and objectives strongly imply that the partner would need demonstrated capability in public health programming, evaluation and research methods, health systems strengthening, and collaboration with Vietnamese institutions and government stakeholders. Because the grant centers on institutional capacity within the GVN and highlights Hanoi Medical University, competitive applicants would typically be expected to show deep experience working within Vietnam's health sector, building sustainable training and mentorship structures, and implementing evaluation and research activities that directly support national program management.
For applicants or stakeholders seeking more information, CDC provided a point of contact through the Procurement and Grants Office technical information management system (PGOTIMS), including a phone number (770-488-2700) and email (pgotim@cdc.gov), particularly for those who had trouble accessing the full announcement electronically. Overall, the opportunity is best understood as a targeted PEPFAR-aligned investment designed to leave behind stronger Vietnamese institutional capability to evaluate and improve HIV/AIDS and public health programs using evidence, coordinated planning, and reinforced health system functions.
Frequently Asked Questions (FAQs)
1) What is the full title of this grant opportunity?
The opportunity is titled "Partnering with Hanoi Medical University to Build Capacity and Implement Program Evaluation, Research, and Health System Strengthening in the Socialist Republic of Vietnam under the President's Emergency Plan for AIDS Relief (PEPFAR)."
2) Who is funding this opportunity?
This is a CDC-funded cooperative agreement.
3) What type of funding mechanism is this?
It is a discretionary cooperative agreement. Compared with a typical grant, this generally indicates substantial CDC involvement in areas such as technical direction, work planning, and performance monitoring.
4) What is the main purpose of the award?
The central purpose is to strengthen Vietnam's public health and HIV response systems by building institutional capacity. The focus is on helping the Government of Vietnam improve how it plans, coordinates, and manages program evaluation and research activities tied to HIV/AIDS and other public health programs, while also strengthening broader health system functions that support effective service delivery.
5) What is the overarching goal of the project?
The overarching goal is to expand institutional capacity within the Vietnamese health system to carry out program evaluation, research, and operations and management functions for HIV/AIDS and related public health priorities.
6) How does Hanoi Medical University fit into the program?
The opportunity explicitly references partnering with Hanoi Medical University, signaling a capacity-building approach that leverages academic and technical institutions as long-term anchors for training, mentorship, analytical support, and implementation science.
7) Is this opportunity limited to HIV activities only?
No. While it is aligned with PEPFAR and HIV/AIDS objectives, the description also emphasizes health system strengthening and mentions HIV/AIDS and other public health programs. The intent includes addressing system-level gaps that affect program performance more broadly.
8) What kinds of activities are emphasized under this award?
Emphasized activities include building stronger mechanisms for monitoring and evaluation, supporting operational research, improving the translation of findings into policy and program adjustments, and strengthening operations and management functions that enable effective service delivery.
9) What does "health system strengthening" mean in the context provided?
Based on the description, health system strengthening is intended to address system-level gaps that affect performance, such as workforce capability, data quality and data use, coordination structures, and management processes.
10) What is the activity category for this opportunity?
The activity category is health.
11) What CFDA number is associated with this award?
The award is linked to CFDA 93.067 (Global AIDS).
12) How many awards were anticipated?
The announcement anticipated a single award, meaning it was designed for one primary implementing partner to lead coordination and execution.
13) What is the estimated total funding amount?
The estimated total funding listed is $3,230,000.
14) What is the award ceiling listed in the source information?
The award ceiling is listed as $230,000 (as presented in the source data).
15) Is cost sharing or matching required?
No. The information provided states that no cost sharing or matching was required.
16) When was the opportunity posted and when did it close?
The opportunity was posted on February 14, 2012. The application closing date was April 16, 2012.
17) What are the "created" and "archive" dates listed for this opportunity?
The opportunity was created on April 7, 2012, and the archive date is May 16, 2012.
18) Who was eligible to apply based on the excerpt?
Eligibility is described broadly as "Others," with further clarification referenced in an additional eligibility section of the full announcement. The excerpt itself does not list specific eligible entity types.
19) What capabilities would competitive applicants likely need, based on the description?
Based on the title and objectives, competitive applicants would likely need demonstrated capability in public health programming, evaluation and research methods, health systems strengthening, and collaboration with Vietnamese institutions and Government of Vietnam stakeholders. The description also implies the value of experience building sustainable training and mentorship structures and implementing evaluation and research activities that support national program management.
20) What is the geographic focus of the work?
The work is focused on the Socialist Republic of Vietnam and aims to strengthen institutional capacity within the Vietnamese health system.
21) How does this opportunity relate to PEPFAR?
The opportunity is framed under the President's Emergency Plan for AIDS Relief (PEPFAR) and is aligned with global HIV/AIDS response objectives, as reflected by the CFDA association with Global AIDS.
22) Why does the opportunity emphasize institutional capacity building?
The description highlights that long-term progress depends not only on program funding, but also on durable national capability to design studies, evaluate performance, use evidence in decision-making, and respond to emerging health system needs identified by the Government of Vietnam and other stakeholders.
23) Where can applicants get help if they cannot access the full announcement electronically?
CDC provided a point of contact through the Procurement and Grants Office technical information management system (PGOTIMS). The phone number listed is 770-488-2700 and the email address is pgotim@cdc.gov.
24) What is the expected role of CDC during the project?
Because this is described as a cooperative agreement, CDC would likely be substantially involved, collaborating on technical direction, work planning, and performance monitoring.
25) What is the intended long-term outcome described for this investment?
The opportunity is described as a targeted PEPFAR-aligned investment intended to leave behind stronger Vietnamese institutional capability to evaluate and improve HIV/AIDS and public health programs using evidence, coordinated planning, and reinforced health system functions.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: SBIR/STTR FY 2012 Phase II
Previous opportunity: Building Construction Technology Extension Program (BCTEP) Pilot Projects
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH12 1232
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH12 1232) also looked into and applied for these:
| Funding Opportunity |
|---|
| PPHF 2012 National Dissemination and Support for Community Transformation Grants financed solely by 2012 Public Prevention Health Fund Apply for CDC RFA DP11 1115PPHF1102CONT12 Funding Number: CDC RFA DP11 1115PPHF1102CONT12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Leadership Education in Adolescent Health Apply for HRSA 12 015 Funding Number: HRSA 12 015 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Mitigate the impact of HIV and AIDS on Zimbabwe s children by enhancing the sustainability of care and support services for Orphans and other Vulnerable Children Apply for 674 12 1008 Funding Number: 674 12 1008 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $20,500,000 |
| Detecting Emerging Vector Borne Zoonotic Pathogens in Indonesia Apply for RFA CK 12 002 Funding Number: RFA CK 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $625,000 |
| Delivering Therapeutics to Residual Active HIV Reservoirs (R01) Apply for PA 12 107 Funding Number: PA 12 107 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health Systems Strengthening Project Apply for RFA 668 12 000001 Funding Number: RFA 668 12 000001 Agency: Sudan USAID Khartoum Category: Health Funding Amount: $25,000,000 |
| Assays for High Throughput Screening (HTS) to Discover Chemical Probes in the Molecular Libraries Probe Production Centers Network (MLPCN) (X01) Apply for PAR 12 108 Funding Number: PAR 12 108 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhancing Engagement and Retention in Quality HIV Care for Transgender Women of Color Demonstration Sites Apply for HRSA 12 099 Funding Number: HRSA 12 099 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Enhancing Engagement and Retention in Quality HIV Care for Transgender Women of Color Evaluation and Technical Assistance Center Apply for HRSA 12 101 Funding Number: HRSA 12 101 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Comprehensive Geriatric Education Program (CGEP) Apply for HRSA 12 004 Funding Number: HRSA 12 004 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Regional HIV/AIDS Prevention and Care Project in West Africa Apply for RFA 624 12 000002 Funding Number: RFA 624 12 000002 Agency: Ghana USAID Accra Category: Health Funding Amount: $13,000,000 |
| Eradication of HIV 1 from CNS Reservoirs Implications for Therapeutics (R01) Apply for RFA MH 13 030 Funding Number: RFA MH 13 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Eradication of HIV 1 from CNS Reservoirs Implications for Therapeutics (R21) Apply for RFA MH 13 031 Funding Number: RFA MH 13 031 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Targeting Persistent HIV Reservoirs (TaPHIR) (R21/R33) Apply for PAR 12 109 Funding Number: PAR 12 109 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44) Apply for RFA HL 13 016 Funding Number: RFA HL 13 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening Safe Hospitals and Clinics in HIV/AIDS Prevention Activities, Services, and Practices in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) CGH/DGHA/Mozambique Apply for CDC RFA PS09 90504CONT12 Funding Number: CDC RFA PS09 90504CONT12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening Capacity through Improved Management and Coordination of Laboratory, Surveillance, Epidemiology Public Health Evaluations and Training in Uganda under PEPFAR Apply for CDC RFA GH12 1212 Funding Number: CDC RFA GH12 1212 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,500,000 |
| Strengthening Human Resource and Institutional Capacity for Delivery of Quality HIV/AIDS, Sexually Transmitted Infection (STI) and Tuberculosis (TB) Services in Local Universities and Surrounding Catchment Areas in Eastern Ethiopia as Part of the Pre Apply for CDC RFA GH12 1221 Funding Number: CDC RFA GH12 1221 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $142,520 |
| Getting from Genes to Function in Lung Disease (R01) Apply for PA 12 110 Funding Number: PA 12 110 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Part C Capacity Development Program Apply for HRSA 12 077 Funding Number: HRSA 12 077 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH12 1232", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.